Skip to main navigation Skip to search Skip to main content

Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response

  • C. M. Fang
  • , S. Roy
  • , E. Nielsen
  • , M. Paul
  • , R. Maul
  • , A. Paun
  • , F. Koentgen
  • , F. M. Raval
  • , E. Szomolanyi-Tsuda
  • , P. M. Pitha

Research output: Contribution to journalArticleResearchpeer-review

Abstract

IRF-5 is a transcription factor activated by toll like receptor (TLR)7 and TLR9 during innate immune responses. IRF-5 activates not only Type I IFN, but also inflammatory cytokines. Most importantly, a genetic variation in the IRF-5 gene shows a strong association with autoimmune diseases such as Lupus. Here, we report that IRF5-deficient mice have attenuated IgG2a/c responses to T-celldependent and-independent antigens and to polyoma virus infection. This defect is due to the intrinsic deletion of IRF-5 in B cells, as SCID mice reconstituted with Irf5-/-B cells show a decrease in IgG2a/c expression after viral infection compared with mice that received wild-type B cells. Irf5-/-B cells in vitro have diminished TLR and cytokine-induced class switching to IgG2a/c. Addressing the molecular mechanism, we show that IRF-5 regulates IgG2a/c expression by decreasing Ikaros expression; reconstitution of IRF-5 in Irf5-/-B cells downregulates Ikaros levels and increases switching to IgG2a/c. The IRF site in ikzf1 promoter binds IRF-5, IRF-4 and IRF-8. We show that IRF-8 but not IRF-4 activates the ikzf1 promoter, and IRF-5 inhibits the transcriptional activity of IRF-8. Collectively, these results identify the IRF-5-Ikaros axis as a critical modulator of IgG2a/c class switching.

Original languageEnglish
Pages (from-to)421-430
Number of pages10
JournalGenes and Immunity
Volume13
Issue number5
DOIs
Publication statusPublished - Jul 2012
Externally publishedYes

Keywords

  • B cells
  • IgG isotype switching
  • Ikaros
  • IRF-5

Cite this